Q1 2024 · 13F-HR
M28 Capital Management LPholdings as filed
Filed 2024-05-14 · accession 0000902664-24-003553
$135.3M
Reported value
11
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $43.2M | 31.9% | 7,000,000 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $41.1M | 30.3% | 9,248,250 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $13.7M | 10.1% | 1,856,117 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $10.4M | 7.68% | 385,680 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $6.5M | 4.78% | 299,400 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $5.4M | 4.02% | 110,400 | Common | SOLE |
| 231269309 | CRIS | CURIS INC | $4.6M | 3.39% | 421,951 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $3.7M | 2.77% | 121,200 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $2.5M | 1.82% | 161,600 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $2.3M | 1.73% | 1,019,498 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $1.9M | 1.42% | 67,400 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.